AVTX vs HLT · P/E 0.0, $51.5M cap vs P/E 51, rev $6.28B
Avalo Therapeutics Inc (AVTX) versus Hilton Worldwide Holdings Inc (HLT) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported HLT revenue for 2026-06-30 was $6.28B. Net income was $867.0M. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
Not investment advice. Open the AVTX and HLT stock pages for the full models.
Not investment advice.